Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica Lee

Showing results (361-370 of 393) with videos related to

Pageof 40
Sort By:
Molecular Therapy Oncolytics|January 6, 2017
Augmentation of cellular and humoral immune responses to HPV16 and HPV18 E6 and E7 antigens by VGX-3100Matthew P Morrow, Kimberly A Kraynyak, Albert J Sylvester, et al.
BMJ Open|February 22, 2023
Lidocaine for Neuropathic Cancer Pain (LiCPain): study protocol for a mixed-methods pilot studyJessica Lee, David Currow, Melanie Lovell, et al.
JAMA Internal Medicine|August 8, 2018
Effect of a Remotely Delivered Tailored Multicomponent Approach to Enhance Medication Taking for Patients With Hyperlipidemia, Hypertension, and Diabetes: The STIC2IT Cluster Randomized Clinical TrialNiteesh K Choudhry, Thomas Isaac, Julie C Lauffenburger, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 16, 2021
How cancer programs identify and address the financial burdens of rural cancer patientsVictoria Petermann, Whitney E Zahnd, Robin C Vanderpool, et al.
American Journal of Ophthalmology|March 15, 2024
An Analysis of Solicitations From Predatory Journals in OphthalmologyGrant A Justin, Charles Huang, Michael K Nguyen, et al.
The Plant Cell|September 5, 2025
Membrane contact sites between chloroplasts and the pathogen interface underpin plant focal immune responsesEnoch Lok Him Yuen, Zachary Savage, Vojtěch Pražák, et al.
ESMO Open|October 24, 2020
Responsiveness to immune checkpoint inhibitors versus other systemic therapies in RET-aberrant malignanciesAparna Hegde, Alexander Y Andreev-Drakhlin, Jason Roszik, et al.
American Journal of Surgery|October 3, 2019
The role of the American Society of anesthesiologists physical status classification in predicting trauma mortality and outcomesCatherine M Kuza, Kazuhide Matsushima, Wendy J Mack, et al.
Cancer Discovery|June 22, 2012
First-in-human trial of a STAT3 decoy oligonucleotide in head and neck tumors: implications for cancer therapyMalabika Sen, Sufi M Thomas, Seungwon Kim, et al.
JCO Precision Oncology|December 24, 2021
Positive Association Between Location of Melanoma, Ultraviolet Signature, Tumor Mutational Burden, and Response to Anti-PD-1 TherapyLéa Dousset, Florence Poizeau, Caroline Robert, et al.
Pageof 40

Showing results (361-370 of 393) with videos related to

Sort By:
Pageof 40
Molecular Therapy Oncolytics|January 6, 2017
Augmentation of cellular and humoral immune responses to HPV16 and HPV18 E6 and E7 antigens by VGX-3100Matthew P Morrow, Kimberly A Kraynyak, Albert J Sylvester, et al.
BMJ Open|February 22, 2023
Lidocaine for Neuropathic Cancer Pain (LiCPain): study protocol for a mixed-methods pilot studyJessica Lee, David Currow, Melanie Lovell, et al.
JAMA Internal Medicine|August 8, 2018
Effect of a Remotely Delivered Tailored Multicomponent Approach to Enhance Medication Taking for Patients With Hyperlipidemia, Hypertension, and Diabetes: The STIC2IT Cluster Randomized Clinical TrialNiteesh K Choudhry, Thomas Isaac, Julie C Lauffenburger, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 16, 2021
How cancer programs identify and address the financial burdens of rural cancer patientsVictoria Petermann, Whitney E Zahnd, Robin C Vanderpool, et al.
American Journal of Ophthalmology|March 15, 2024
An Analysis of Solicitations From Predatory Journals in OphthalmologyGrant A Justin, Charles Huang, Michael K Nguyen, et al.
The Plant Cell|September 5, 2025
Membrane contact sites between chloroplasts and the pathogen interface underpin plant focal immune responsesEnoch Lok Him Yuen, Zachary Savage, Vojtěch Pražák, et al.
ESMO Open|October 24, 2020
Responsiveness to immune checkpoint inhibitors versus other systemic therapies in RET-aberrant malignanciesAparna Hegde, Alexander Y Andreev-Drakhlin, Jason Roszik, et al.
American Journal of Surgery|October 3, 2019
The role of the American Society of anesthesiologists physical status classification in predicting trauma mortality and outcomesCatherine M Kuza, Kazuhide Matsushima, Wendy J Mack, et al.
Cancer Discovery|June 22, 2012
First-in-human trial of a STAT3 decoy oligonucleotide in head and neck tumors: implications for cancer therapyMalabika Sen, Sufi M Thomas, Seungwon Kim, et al.
JCO Precision Oncology|December 24, 2021
Positive Association Between Location of Melanoma, Ultraviolet Signature, Tumor Mutational Burden, and Response to Anti-PD-1 TherapyLéa Dousset, Florence Poizeau, Caroline Robert, et al.
Pageof 40